 Catherine Demers
Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| White Matter | 1 | 2021 | 104 | 0.700 |
Why?
| | Amygdala | 3 | 2022 | 170 | 0.540 |
Why?
| | Arachidonic Acids | 1 | 2016 | 56 | 0.520 |
Why?
| | Endocannabinoids | 1 | 2016 | 36 | 0.510 |
Why?
| | Corticotropin-Releasing Hormone | 1 | 2016 | 67 | 0.500 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2016 | 1879 | 0.380 |
Why?
| | Anxiety | 1 | 2016 | 840 | 0.330 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2022 | 452 | 0.270 |
Why?
| | Psychotherapy, Brief | 1 | 2023 | 28 | 0.210 |
Why?
| | Signal Transduction | 1 | 2016 | 4509 | 0.210 |
Why?
| | Brain | 4 | 2021 | 2371 | 0.210 |
Why?
| | Diffusion Tensor Imaging | 1 | 2021 | 63 | 0.190 |
Why?
| | Magnetic Resonance Imaging | 6 | 2022 | 3039 | 0.190 |
Why?
| | Social Behavior | 2 | 2013 | 267 | 0.180 |
Why?
| | Prospective Studies | 5 | 2023 | 6214 | 0.180 |
Why?
| | Pregnancy | 5 | 2023 | 5517 | 0.180 |
Why?
| | Depressive Disorder, Major | 1 | 2023 | 301 | 0.170 |
Why?
| | Racism | 1 | 2021 | 102 | 0.170 |
Why?
| | Stress, Psychological | 3 | 2017 | 944 | 0.170 |
Why?
| | Premature Birth | 1 | 2022 | 276 | 0.160 |
Why?
| | Psychoses, Substance-Induced | 1 | 2019 | 12 | 0.160 |
Why?
| | Gray Matter | 1 | 2019 | 67 | 0.160 |
Why?
| | Genetic Predisposition to Disease | 2 | 2019 | 2084 | 0.160 |
Why?
| | Sex Characteristics | 2 | 2013 | 640 | 0.160 |
Why?
| | Depression | 3 | 2023 | 1133 | 0.140 |
Why?
| | Frontal Lobe | 1 | 2017 | 141 | 0.130 |
Why?
| | Marijuana Abuse | 1 | 2019 | 212 | 0.130 |
Why?
| | Polyunsaturated Alkamides | 1 | 2016 | 7 | 0.130 |
Why?
| | Amidohydrolases | 1 | 2016 | 28 | 0.130 |
Why?
| | Receptors, Corticotropin-Releasing Hormone | 1 | 2016 | 32 | 0.130 |
Why?
| | Genome-Wide Association Study | 2 | 2019 | 1177 | 0.130 |
Why?
| | Female | 15 | 2023 | 59461 | 0.120 |
Why?
| | Longitudinal Studies | 1 | 2021 | 2387 | 0.120 |
Why?
| | Perception | 1 | 2017 | 311 | 0.120 |
Why?
| | Receptors, AMPA | 1 | 2015 | 119 | 0.120 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2016 | 482 | 0.110 |
Why?
| | Touch | 1 | 2013 | 30 | 0.110 |
Why?
| | Impulsive Behavior | 1 | 2013 | 113 | 0.100 |
Why?
| | Maternal Behavior | 1 | 2013 | 70 | 0.100 |
Why?
| | Cocaine-Related Disorders | 1 | 2013 | 107 | 0.100 |
Why?
| | Self Concept | 1 | 2013 | 213 | 0.100 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2016 | 682 | 0.100 |
Why?
| | Oxygen | 1 | 2016 | 854 | 0.090 |
Why?
| | Genotype | 1 | 2016 | 1760 | 0.090 |
Why?
| | Self Care | 1 | 2013 | 349 | 0.090 |
Why?
| | Humans | 14 | 2023 | 114616 | 0.090 |
Why?
| | Behavior, Animal | 1 | 2013 | 458 | 0.080 |
Why?
| | Cognitive Dysfunction | 1 | 2013 | 284 | 0.080 |
Why?
| | Infant | 1 | 2021 | 7954 | 0.080 |
Why?
| | Opioid-Related Disorders | 1 | 2015 | 413 | 0.080 |
Why?
| | Siblings | 2 | 2019 | 221 | 0.070 |
Why?
| | Male | 11 | 2022 | 55549 | 0.070 |
Why?
| | Adult | 7 | 2023 | 30528 | 0.070 |
Why?
| | Young Adult | 2 | 2016 | 10455 | 0.060 |
Why?
| | Telomere Shortening | 1 | 2022 | 17 | 0.050 |
Why?
| | Infant, Newborn | 2 | 2022 | 5040 | 0.050 |
Why?
| | Heart Failure | 1 | 2013 | 1945 | 0.040 |
Why?
| | Telomere | 1 | 2022 | 202 | 0.040 |
Why?
| | Retrospective Studies | 1 | 2016 | 12542 | 0.040 |
Why?
| | Neuropsychological Tests | 2 | 2013 | 927 | 0.040 |
Why?
| | Interview, Psychological | 1 | 2019 | 86 | 0.040 |
Why?
| | Hippocampus | 1 | 2022 | 693 | 0.040 |
Why?
| | Cholecalciferol | 2 | 1995 | 47 | 0.040 |
Why?
| | Calcitriol | 2 | 1995 | 53 | 0.040 |
Why?
| | Diseases in Twins | 1 | 2019 | 174 | 0.040 |
Why?
| | Sleep | 1 | 2022 | 631 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2019 | 4405 | 0.030 |
Why?
| | Steroid Hydroxylases | 1 | 1995 | 19 | 0.030 |
Why?
| | Habituation, Psychophysiologic | 1 | 2015 | 48 | 0.030 |
Why?
| | Vitamin D Deficiency | 2 | 1995 | 158 | 0.030 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 1995 | 108 | 0.030 |
Why?
| | Mice, Inbred Strains | 1 | 2015 | 396 | 0.030 |
Why?
| | Intestine, Small | 1 | 1995 | 122 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 3 | 2013 | 2218 | 0.030 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 1995 | 270 | 0.030 |
Why?
| | Species Specificity | 1 | 2015 | 542 | 0.030 |
Why?
| | Alcohol Drinking | 1 | 2019 | 651 | 0.030 |
Why?
| | Judgment | 1 | 2013 | 55 | 0.030 |
Why?
| | Receptors, Dopamine | 1 | 2013 | 12 | 0.030 |
Why?
| | Hypocalcemia | 1 | 1993 | 31 | 0.030 |
Why?
| | Video Recording | 1 | 2013 | 143 | 0.030 |
Why?
| | Tyrosine 3-Monooxygenase | 1 | 2013 | 68 | 0.030 |
Why?
| | Receptor, Serotonin, 5-HT2A | 1 | 2013 | 19 | 0.030 |
Why?
| | Task Performance and Analysis | 1 | 2013 | 159 | 0.030 |
Why?
| | Corpus Striatum | 1 | 2013 | 126 | 0.030 |
Why?
| | Calcium | 2 | 1995 | 1104 | 0.030 |
Why?
| | Communication Barriers | 1 | 2013 | 89 | 0.030 |
Why?
| | RNA, Messenger | 3 | 2013 | 2552 | 0.020 |
Why?
| | Child | 2 | 2022 | 18402 | 0.020 |
Why?
| | Middle Aged | 3 | 2019 | 26719 | 0.020 |
Why?
| | Registries | 1 | 2019 | 1767 | 0.020 |
Why?
| | Rats | 3 | 2013 | 4958 | 0.020 |
Why?
| | Residence Characteristics | 1 | 2013 | 275 | 0.020 |
Why?
| | Recurrence | 1 | 2013 | 935 | 0.020 |
Why?
| | Cerebral Cortex | 1 | 2013 | 380 | 0.020 |
Why?
| | Brain Mapping | 1 | 2013 | 524 | 0.020 |
Why?
| | ErbB Receptors | 1 | 1993 | 554 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2023 | 9084 | 0.020 |
Why?
| | Executive Function | 1 | 2013 | 379 | 0.020 |
Why?
| | Patient Care Team | 1 | 2013 | 517 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2013 | 3001 | 0.020 |
Why?
| | Mass Screening | 1 | 2013 | 1004 | 0.020 |
Why?
| | Animals | 4 | 2015 | 31692 | 0.020 |
Why?
| | Age Factors | 1 | 2013 | 2894 | 0.020 |
Why?
| | Cognition | 1 | 2013 | 988 | 0.020 |
Why?
| | Liver | 1 | 1993 | 1633 | 0.020 |
Why?
| | Risk Factors | 1 | 2019 | 8628 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2013 | 2319 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2013 | 6344 | 0.010 |
Why?
| | Adolescent | 1 | 2019 | 17830 | 0.010 |
Why?
| | Vitamin D3 24-Hydroxylase | 1 | 1995 | 14 | 0.010 |
Why?
| | DNA Probes | 1 | 1995 | 59 | 0.010 |
Why?
| | Enzyme Induction | 1 | 1995 | 84 | 0.010 |
Why?
| | Blotting, Northern | 1 | 1995 | 193 | 0.010 |
Why?
| | Aged | 1 | 2013 | 19061 | 0.010 |
Why?
| | Transforming Growth Factor alpha | 1 | 1993 | 53 | 0.010 |
Why?
| | Down-Regulation | 1 | 1995 | 594 | 0.010 |
Why?
| | Epidermal Growth Factor | 1 | 1993 | 161 | 0.010 |
Why?
| | Analysis of Variance | 1 | 1995 | 1226 | 0.010 |
Why?
| | Phosphorylation | 1 | 1993 | 1569 | 0.010 |
Why?
|
|
Demers's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|